i
Syringe exchange programs: lowering the transmission of syringe-borne diseases and beyond.
-
Jun 1998
By Heimer, RSource: Public Health Rep. 113(Suppl 1):67-74
Details:
-
Alternative Title:Public Health Rep
-
Personal Author:
-
Description:This chapter attempts to describe the factors influencing the transmission of syringe-born viruses, to review the effects of syringe exchange programs (SEPs) in terms of these factors, and to explore the gamut of health-promoting activities of SEPs.|The chapter is divided into six sections: biological factors in syringe-borne viral transmission, behavior and viral transmission, quantifying viral transmission, preventing viral transmission, impediments to preventing viral transmission, and research for preventing viral transmission. Understanding how biological and behavioral factors influence transmission of human immunodeficiency virus (HIV) and hepatitis builds a framework to investigate the epidemiology and the impact of SEPs on disease transmission. Even under circumstances in which these programs do not appear to be effective, understanding the implications of the biological and behavioral factors can contribute to our understanding of program benefits and limitations. Furthermore, program benefits may not be restricted to direct effects on disease transmission. Many programs offer services to drug injectors that include risk reduction training, facilitated entry into substance abuse treatment, and medical care.|SEPs can reduce the transmission of syringe-borne viruses without increasing illicit drug use. However, lack of resources, acceptance, and consequently, protection of many of those at risk when they are most vulnerable have hampered program effectiveness. New studies need to be designed to explicate the full measure of program benefit within covered communities and identify the means by which SEPs can expand benefit to individuals at greatest risk.
-
Subject:
-
Pubmed ID:9722811
-
Pubmed Central ID:PMCnull
-
Document Type:
-
Place as Subject:
-
Collection(s):
-
Main Document Checksum:urn:sha256:e76bed264c63180e109444dbbbee013366bbe9cc788039ec08ae6be589fdde10
-
File Type:
Supporting Files
-
No Additional Files
More +
Related Documents
-
- File Format:
- RIS
- File Format:
- RIS
- File Format:
- RIS
- File Format:
- RIS
- File Format:
- RIS
- File Format:
- RIS
- File Format:
- RIS
- File Format:
- RIS
- File Format:
- RIS
Outreach-based HIV prevention for injecting drug users: a review of published outcome data.CitePersonal Author:Coyle, S L ;Needle, R H...Jun 1998 | Public Health Rep. 113(Suppl 1):19-30Description:Over the past decade, a body of observational research has accrued about the effects of outreach-based human immunodeficiency virus (HIV) intervention...Peer-delivered interventions reduce HIV risk behaviors among out-of-treatment drug abusers.CitePersonal Author:Cottler, L B ;Compton, W M...Jun 1998 | Public Health Rep. 113(Suppl 1):31-41Description:The purpose of this chapter is to describe the results of a randomized study (funded by the National Institute on Drug Abuse [NIDA]) comparing a peer-...Community-based outreach HIV intervention for street-recruited drug users in Madras, India.CitePersonal Author:Kumar, M S ;Mudaliar, S...Jun 1998 | Public Health Rep. 113(Suppl 1):58-66Description:Community-based outreach to drug injectors is an important component of human immunodeficiency virus (HIV) prevention strategy. The purpose of this ch...Pharmacy access to syringes among injecting drug users: follow-up findings from Hartford, Connecticut.CitePersonal Author:Singer, M ;Baer, H A...Jun 1998 | Public Health Rep. 113(Suppl 1):81-89Description:To break the link between drug use and the human immunodeficiency virus (HIV), in 1992 the state of Connecticut rescinded a 14-year ban on pharmacy sa...Personal Author:Levy, J A ;Fox, S EJun 1998 | Public Health Rep. 113(Suppl 1):160-169Description:This analysis describes the Outreach-Assisted Model of Partner Notification, an innovative strategy for encouraging seropositive injecting drug users ...Personal Author:Metzger, D S ;Navaline, H...Jun 1998 | Public Health Rep. 113(Suppl 1):97-106Description:As the acquired immunodeficiency syndrome (AIDS) epidemic among drug users enters its third decade in the United States, it is important to consider t...HIV prevention with drug using populations. Current status and future prospects.CiteHarnessing peer networks as an instrument for AIDS prevention: results from a peer-driven intervention.CitePersonal Author:Broadhead, R S ;Heckathorn, D D...Jun 1998 | Public Health Rep. 113(Suppl 1):42-57Description:Since 1985, community outreach efforts to combat acquired immunodeficiency syndrome (AIDS) among injecting drug users (IDUs) in the United States have...Personal Author:Vlahov, D ;Junge, BJun 1998 | Public Health Rep. 113(Suppl 1):75-80Description:Injecting drug users (IDUs) are at high risk for infection by human immunodeficiency virus (HIV) and other blood-borne pathogens. In the United States...Fifteen years of research on preventing HIV infection among injecting drug users: what we have learned, what we have not learned, what we have done, what we have not done.CitePersonal Author:Des Jarlais, D C ;Friedman, S RJun 1998 | Public Health Rep. 113(Suppl 1):182-188Description:Acquired immunodeficiency syndrome (AIDS) was formally identified among injecting drug users (IDUs) in 1981, and research on preventing human immunode...Bridging the gap between science and practice: insight to researchers from practitioners.CitePersonal Author:Shriver, M ;de Burger, R...Jun 1998 | Public Health Rep. 113(Suppl 1):189-193Description:Five policy advocates and practitioners provide recommendations to researchers to make research data more usable, accessible, and applicable for the f...Personal Author:Booth, R E ;Kwiatkowski, C...Jun 1998 | Public Health Rep. 113(Suppl 1):116-128Description:High risk injection practices are common among injecting drug users (IDUs), even following intervention efforts. Moreover, relapse to risk behaviors h...Personal Author:Brooner, R ;Kidorf, M...Jun 1998 | Public Health Rep. 113(Suppl 1):129-139Description:Although lowering incidence rates of human immunodeficiency virus (HIV) transmission is the primary goal of needle exchange programs (NEPs), other des...Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City.CitePersonal Author:Hartel, D M ;Schoenbaum, E EJun 1998 | Public Health Rep. 113(Suppl 1):107-115Description:We undertook a study of the role of methadone maintenance in protecting injecting drug users (IDUs) from human immunodeficiency virus (HIV) infection ...
More +
You May Also Like
Personal Author:
Vlahov, D ;
Junge, B
Jun 1998 | Public Health Rep. 113(Suppl 1):75-80
Description:
Injecting drug users (IDUs) are at high risk for infection by human immunodeficiency virus (HIV) and other blood-borne pathogens. In the United States...
Checkout today's featured content at stacks.cdc.gov